Abstract
While the European Commission tries to rewrite the regulations for conducting clinical trials, some academics under the umbrella of the Sensible Guidelines Group are taking matters into their own hands and urging a return to the basic principles of randomized clinical trials, reports Barry Shurlock PhD, in conversation with Prof. Sir Rory Collins, Oxford University, UK